PLAY PODCASTS
Beyond Viral Suppression: A Case Study Addressing Internalized HIV Stigma
Episode 381

Beyond Viral Suppression: A Case Study Addressing Internalized HIV Stigma

Learn from Gregory Huhn, MD, MPHTM, about why sometimes viral suppression is not enough to achieve optimal health outcomes for people living with HIV. Listen in as we explore optimizing ART to address internalized stigma in the setting of virologic suppression.

Decera Clinical Education Infectious Disease Podcast · Gregory Huhn MD MPHTM

April 11, 202412m 29s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Gregory Huhn, MD, MPHTM, uses a case study to explore the reasons healthcare professionals and people living with HIV may want to further optimize ART in the setting of viral suppression. 

To determine the best outcome for this case study, Dr Huhn discusses the reasons individuals may not be satisfied with daily oral ART and examines data to suggest that, for some individuals with virologic suppression, switching to long-acting ART may address internalized HIV stigma.

Finally, Dr Huhn takes a look at the optimal candidates for switching to a long-acting ART regimen and settings where proviral DNA genotyping may be considered prior to switching.

Presenter:

Gregory Huhn, MD, MPHTM
Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, Illinois

To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

See the full program here.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

case studymdvirologic suppressionlong-acting cabotegravir/rilpivirineviral suppressionantiretroviral therapyhiv-1internalized stigmala-cab rpvmphtmart resistancelong-acting antiretroviral therapystigmagregory huhnla-artarthiv